Literature DB >> 1690030

Use of molecular probes to study regulation of aromatase cytochrome P-450.

C R Mendelson1, G D Means, M S Mahendroo, C J Corbin, M P Steinkampf, S Graham-Lorence, E R Simpson.   

Abstract

Aromatase, an enzyme complex localized in the endoplasmic reticulum of estrogen-producing cells, is composed of NADPH-cytochrome P-450 reductase, and aromatase cytochrome P-450 (cytochrome P-450AROM). To define the molecular mechanisms involved in the multifactorial regulation of cytochrome P-450AROM in estrogen-producing cells, we have isolated a cDNA specific for human cytochrome P-450AROM and have used this cDNA to isolate the human cytochrome P-450AROM gene. The cDNA sequence encodes a polypeptide of 503 amino acids and contains--near the carboxy-terminus, a region of high homology with the putative heme-binding regions of other P-450 cytochromes. COS1 cells transfected with an expression plasmid containing the cytochrome P-450AROM cDNA had the capacity to aromatize testosterone, androstenedione and 16 alpha-hydroxyandrostenedione, suggesting that a single polypeptide catalyzes all steps of the aromatization reaction using either of the three major C19-substrates. The human cytochrome P-450AROM gene is greater than 52 kb in size and consists of 10 exons and 9 introns. Hormonally induced changes in aromatase activity of human ovarian granulosa and adipose stromal cells are associated with comparable changes in cytochrome P-450AROM gene expression and synthesis, whereas the reductase component is only modestly affected. Studies are in progress to define the molecular mechanisms involved in the regulation of cytochrome P-450AROM gene expression in estrogen-producing cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690030     DOI: 10.1095/biolreprod42.1.1

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  4 in total

1.  Rat Sertoli cell aromatase cytochrome P450: regulation by cell culture conditions and relationship to the state of cell differentiation.

Authors:  V Papadopoulos; M C Jia; M Culty; P F Hall; M Dym
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-12       Impact factor: 2.416

2.  Association of genetic polymorphisms in CYP19A1 and blood levels of sex hormones among postmenopausal Chinese women.

Authors:  Hui Cai; Xiao Ou Shu; Kathleen M Egan; Qiuyin Cai; Ji-Rong Long; Yu-Tang Gao; Wei Zheng
Journal:  Pharmacogenet Genomics       Date:  2008-08       Impact factor: 2.089

3.  A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives.

Authors:  Zhen Hu; Chuan-Gui Song; Jing-Song Lu; Jian-Min Luo; Zhen-Zhou Shen; Wei Huang; Zhi-Ming Shao
Journal:  J Cancer Res Clin Oncol       Date:  2007-06-12       Impact factor: 4.553

4.  The (TTTA)n polymorphism in intron 4 of CYP19 and the polycystic ovary syndrome risk in a Chinese population.

Authors:  P Xu; X L Zhang; G B Xie; C W Zhang; S M Shen; X X Zhang; Y X Cao; W J Wang; Y N Che; Y J Xia; X K Wu; L Yi; Q Gao; Y Wang
Journal:  Mol Biol Rep       Date:  2013-05-10       Impact factor: 2.316

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.